Review



cgrp fragment 8 37  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress cgrp fragment 8 37
    Cgrp Fragment 8 37, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgrp fragment 8 37/product/MedChemExpress
    Average 94 stars, based on 15 article reviews
    cgrp fragment 8 37 - by Bioz Stars, 2026-04
    94/100 stars

    Images



    Similar Products

    94
    MedChemExpress cgrp fragment 8 37
    Cgrp Fragment 8 37, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgrp fragment 8 37/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    cgrp fragment 8 37 - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    90
    Phoenix Pharmaceuticals calcitonin gene–related peptide fragment 8 37 (human cgrp 8-37
    Calcitonin Gene–Related Peptide Fragment 8 37 (Human Cgrp 8 37, supplied by Phoenix Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/calcitonin gene–related peptide fragment 8 37 (human cgrp 8-37/product/Phoenix Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    calcitonin gene–related peptide fragment 8 37 (human cgrp 8-37 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Millipore cgrp fragment 8–37
    SP and CGRP neutralization reverses DRG-induced EMT and FMT in 11Z cells. ( A ) Representative morphology of 11Z cells treated with medium, the DRG supernatant with pre-treatment with aprepitant (10 −6 M), CGRP fragment 8–37 (10 −6 M), or both aprepitant (10 −6 M) and CGRP 8–37 (10 −6 M), or without for 12 days. Scale bar = 100 μm. ( B ) Left panel: Detection of protein levels of E-cadherin by immunoblotting of lysates of 11Z cells treated with indicated condition for 12 days (n = 3). The grouping of blots from the same protein were not cropped, and all protein blots were from the same gel. Right panel: Relative fold change in protein levels of E-cadherin in 11Z cells treated with indicated condition for 12 days (n = 3). ( C ) Relative fold change of gene expression levels of Snai1, Slug, vimentin, N-cadherin, and PAI-1 in 11Z cells treated with indicated conditions for 12 days (n = 3). Values are normalized to the GAPDH expression levels. ( D ) Results of SP and CGRP neutralization on cellular proliferation of 11Z cells, as measured by CCK-8 assay (n = 8). The 11Z cells were treated with the indicated conditions for 12 days. ( E ) Results of SP and CGRP neutralization on cell migratory capacity, as evaluated by the scratch assay, of 11Z cells treated with indicated conditions for 12 days. The cells were photographed at 0, 12, 24 and 48 hours, respectively, after being scratched. The distance between two edges that cells traversed was calculated relative to the initial scratch distance as measured with pixel values. Scale bar = 100 μm. ( F ) Results of SP and CGRP neutralization on invasiveness. The representative photomicrographs of the invaded 11Z cells in the transwell assay after indicated treatments (Magnification: × 200). Cells, after 12 days’ indicated treatments, were added to the top of transwells coated with Matrigel and treated as indicated. The total number of cells invaded to the bottom of the transwell was then counted. Scale bar = 100 μm. * or # p < 0.05, ** or ## p < 0.01, *** or ### p < 0.001; N: not statistically significant (p > 0.05). Data are represented in means ± SDs. Symbols of statistical significance: *, **, and *** indicate different significant levels when compared with the untreated cells, while #, ## , and ### indicate different significant levels when compared with the cells treated with the DRG supernatant. * or # p < 0.05; ** or ## p < 0.01; *** or ### p < 0.001.
    Cgrp Fragment 8–37, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgrp fragment 8–37/product/Millipore
    Average 90 stars, based on 1 article reviews
    cgrp fragment 8–37 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Millipore calcitonin gene-related peptide receptor antagonist fragment 8–37 (cgrp 8-37
    SP and CGRP neutralization reverses DRG-induced EMT and FMT in 11Z cells. ( A ) Representative morphology of 11Z cells treated with medium, the DRG supernatant with pre-treatment with aprepitant (10 −6 M), CGRP fragment 8–37 (10 −6 M), or both aprepitant (10 −6 M) and CGRP 8–37 (10 −6 M), or without for 12 days. Scale bar = 100 μm. ( B ) Left panel: Detection of protein levels of E-cadherin by immunoblotting of lysates of 11Z cells treated with indicated condition for 12 days (n = 3). The grouping of blots from the same protein were not cropped, and all protein blots were from the same gel. Right panel: Relative fold change in protein levels of E-cadherin in 11Z cells treated with indicated condition for 12 days (n = 3). ( C ) Relative fold change of gene expression levels of Snai1, Slug, vimentin, N-cadherin, and PAI-1 in 11Z cells treated with indicated conditions for 12 days (n = 3). Values are normalized to the GAPDH expression levels. ( D ) Results of SP and CGRP neutralization on cellular proliferation of 11Z cells, as measured by CCK-8 assay (n = 8). The 11Z cells were treated with the indicated conditions for 12 days. ( E ) Results of SP and CGRP neutralization on cell migratory capacity, as evaluated by the scratch assay, of 11Z cells treated with indicated conditions for 12 days. The cells were photographed at 0, 12, 24 and 48 hours, respectively, after being scratched. The distance between two edges that cells traversed was calculated relative to the initial scratch distance as measured with pixel values. Scale bar = 100 μm. ( F ) Results of SP and CGRP neutralization on invasiveness. The representative photomicrographs of the invaded 11Z cells in the transwell assay after indicated treatments (Magnification: × 200). Cells, after 12 days’ indicated treatments, were added to the top of transwells coated with Matrigel and treated as indicated. The total number of cells invaded to the bottom of the transwell was then counted. Scale bar = 100 μm. * or # p < 0.05, ** or ## p < 0.01, *** or ### p < 0.001; N: not statistically significant (p > 0.05). Data are represented in means ± SDs. Symbols of statistical significance: *, **, and *** indicate different significant levels when compared with the untreated cells, while #, ## , and ### indicate different significant levels when compared with the cells treated with the DRG supernatant. * or # p < 0.05; ** or ## p < 0.01; *** or ### p < 0.001.
    Calcitonin Gene Related Peptide Receptor Antagonist Fragment 8–37 (Cgrp 8 37, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/calcitonin gene-related peptide receptor antagonist fragment 8–37 (cgrp 8-37/product/Millipore
    Average 90 stars, based on 1 article reviews
    calcitonin gene-related peptide receptor antagonist fragment 8–37 (cgrp 8-37 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Peptide Institute cgrp fragment (8–37)
    SP and CGRP neutralization reverses DRG-induced EMT and FMT in 11Z cells. ( A ) Representative morphology of 11Z cells treated with medium, the DRG supernatant with pre-treatment with aprepitant (10 −6 M), CGRP fragment 8–37 (10 −6 M), or both aprepitant (10 −6 M) and CGRP 8–37 (10 −6 M), or without for 12 days. Scale bar = 100 μm. ( B ) Left panel: Detection of protein levels of E-cadherin by immunoblotting of lysates of 11Z cells treated with indicated condition for 12 days (n = 3). The grouping of blots from the same protein were not cropped, and all protein blots were from the same gel. Right panel: Relative fold change in protein levels of E-cadherin in 11Z cells treated with indicated condition for 12 days (n = 3). ( C ) Relative fold change of gene expression levels of Snai1, Slug, vimentin, N-cadherin, and PAI-1 in 11Z cells treated with indicated conditions for 12 days (n = 3). Values are normalized to the GAPDH expression levels. ( D ) Results of SP and CGRP neutralization on cellular proliferation of 11Z cells, as measured by CCK-8 assay (n = 8). The 11Z cells were treated with the indicated conditions for 12 days. ( E ) Results of SP and CGRP neutralization on cell migratory capacity, as evaluated by the scratch assay, of 11Z cells treated with indicated conditions for 12 days. The cells were photographed at 0, 12, 24 and 48 hours, respectively, after being scratched. The distance between two edges that cells traversed was calculated relative to the initial scratch distance as measured with pixel values. Scale bar = 100 μm. ( F ) Results of SP and CGRP neutralization on invasiveness. The representative photomicrographs of the invaded 11Z cells in the transwell assay after indicated treatments (Magnification: × 200). Cells, after 12 days’ indicated treatments, were added to the top of transwells coated with Matrigel and treated as indicated. The total number of cells invaded to the bottom of the transwell was then counted. Scale bar = 100 μm. * or # p < 0.05, ** or ## p < 0.01, *** or ### p < 0.001; N: not statistically significant (p > 0.05). Data are represented in means ± SDs. Symbols of statistical significance: *, **, and *** indicate different significant levels when compared with the untreated cells, while #, ## , and ### indicate different significant levels when compared with the cells treated with the DRG supernatant. * or # p < 0.05; ** or ## p < 0.01; *** or ### p < 0.001.
    Cgrp Fragment (8–37), supplied by Peptide Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgrp fragment (8–37)/product/Peptide Institute
    Average 90 stars, based on 1 article reviews
    cgrp fragment (8–37) - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Millipore cgrp fragment 8–37 (α‐cgrp 8–37, 3125.59da; 30 amino acids, referred to as cgrp)
    SP and CGRP neutralization reverses DRG-induced EMT and FMT in 11Z cells. ( A ) Representative morphology of 11Z cells treated with medium, the DRG supernatant with pre-treatment with aprepitant (10 −6 M), CGRP fragment 8–37 (10 −6 M), or both aprepitant (10 −6 M) and CGRP 8–37 (10 −6 M), or without for 12 days. Scale bar = 100 μm. ( B ) Left panel: Detection of protein levels of E-cadherin by immunoblotting of lysates of 11Z cells treated with indicated condition for 12 days (n = 3). The grouping of blots from the same protein were not cropped, and all protein blots were from the same gel. Right panel: Relative fold change in protein levels of E-cadherin in 11Z cells treated with indicated condition for 12 days (n = 3). ( C ) Relative fold change of gene expression levels of Snai1, Slug, vimentin, N-cadherin, and PAI-1 in 11Z cells treated with indicated conditions for 12 days (n = 3). Values are normalized to the GAPDH expression levels. ( D ) Results of SP and CGRP neutralization on cellular proliferation of 11Z cells, as measured by CCK-8 assay (n = 8). The 11Z cells were treated with the indicated conditions for 12 days. ( E ) Results of SP and CGRP neutralization on cell migratory capacity, as evaluated by the scratch assay, of 11Z cells treated with indicated conditions for 12 days. The cells were photographed at 0, 12, 24 and 48 hours, respectively, after being scratched. The distance between two edges that cells traversed was calculated relative to the initial scratch distance as measured with pixel values. Scale bar = 100 μm. ( F ) Results of SP and CGRP neutralization on invasiveness. The representative photomicrographs of the invaded 11Z cells in the transwell assay after indicated treatments (Magnification: × 200). Cells, after 12 days’ indicated treatments, were added to the top of transwells coated with Matrigel and treated as indicated. The total number of cells invaded to the bottom of the transwell was then counted. Scale bar = 100 μm. * or # p < 0.05, ** or ## p < 0.01, *** or ### p < 0.001; N: not statistically significant (p > 0.05). Data are represented in means ± SDs. Symbols of statistical significance: *, **, and *** indicate different significant levels when compared with the untreated cells, while #, ## , and ### indicate different significant levels when compared with the cells treated with the DRG supernatant. * or # p < 0.05; ** or ## p < 0.01; *** or ### p < 0.001.
    Cgrp Fragment 8–37 (α‐Cgrp 8–37, 3125.59da; 30 Amino Acids, Referred To As Cgrp), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgrp fragment 8–37 (α‐cgrp 8–37, 3125.59da; 30 amino acids, referred to as cgrp)/product/Millipore
    Average 90 stars, based on 1 article reviews
    cgrp fragment 8–37 (α‐cgrp 8–37, 3125.59da; 30 amino acids, referred to as cgrp) - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Millipore cgrp receptor antagonist c-2806 8-37 peptide fragment
    SP and CGRP neutralization reverses DRG-induced EMT and FMT in 11Z cells. ( A ) Representative morphology of 11Z cells treated with medium, the DRG supernatant with pre-treatment with aprepitant (10 −6 M), CGRP fragment 8–37 (10 −6 M), or both aprepitant (10 −6 M) and CGRP 8–37 (10 −6 M), or without for 12 days. Scale bar = 100 μm. ( B ) Left panel: Detection of protein levels of E-cadherin by immunoblotting of lysates of 11Z cells treated with indicated condition for 12 days (n = 3). The grouping of blots from the same protein were not cropped, and all protein blots were from the same gel. Right panel: Relative fold change in protein levels of E-cadherin in 11Z cells treated with indicated condition for 12 days (n = 3). ( C ) Relative fold change of gene expression levels of Snai1, Slug, vimentin, N-cadherin, and PAI-1 in 11Z cells treated with indicated conditions for 12 days (n = 3). Values are normalized to the GAPDH expression levels. ( D ) Results of SP and CGRP neutralization on cellular proliferation of 11Z cells, as measured by CCK-8 assay (n = 8). The 11Z cells were treated with the indicated conditions for 12 days. ( E ) Results of SP and CGRP neutralization on cell migratory capacity, as evaluated by the scratch assay, of 11Z cells treated with indicated conditions for 12 days. The cells were photographed at 0, 12, 24 and 48 hours, respectively, after being scratched. The distance between two edges that cells traversed was calculated relative to the initial scratch distance as measured with pixel values. Scale bar = 100 μm. ( F ) Results of SP and CGRP neutralization on invasiveness. The representative photomicrographs of the invaded 11Z cells in the transwell assay after indicated treatments (Magnification: × 200). Cells, after 12 days’ indicated treatments, were added to the top of transwells coated with Matrigel and treated as indicated. The total number of cells invaded to the bottom of the transwell was then counted. Scale bar = 100 μm. * or # p < 0.05, ** or ## p < 0.01, *** or ### p < 0.001; N: not statistically significant (p > 0.05). Data are represented in means ± SDs. Symbols of statistical significance: *, **, and *** indicate different significant levels when compared with the untreated cells, while #, ## , and ### indicate different significant levels when compared with the cells treated with the DRG supernatant. * or # p < 0.05; ** or ## p < 0.01; *** or ### p < 0.001.
    Cgrp Receptor Antagonist C 2806 8 37 Peptide Fragment, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgrp receptor antagonist c-2806 8-37 peptide fragment/product/Millipore
    Average 90 stars, based on 1 article reviews
    cgrp receptor antagonist c-2806 8-37 peptide fragment - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Peptide Institute cgrp and its fragment (8–37)
    SP and CGRP neutralization reverses DRG-induced EMT and FMT in 11Z cells. ( A ) Representative morphology of 11Z cells treated with medium, the DRG supernatant with pre-treatment with aprepitant (10 −6 M), CGRP fragment 8–37 (10 −6 M), or both aprepitant (10 −6 M) and CGRP 8–37 (10 −6 M), or without for 12 days. Scale bar = 100 μm. ( B ) Left panel: Detection of protein levels of E-cadherin by immunoblotting of lysates of 11Z cells treated with indicated condition for 12 days (n = 3). The grouping of blots from the same protein were not cropped, and all protein blots were from the same gel. Right panel: Relative fold change in protein levels of E-cadherin in 11Z cells treated with indicated condition for 12 days (n = 3). ( C ) Relative fold change of gene expression levels of Snai1, Slug, vimentin, N-cadherin, and PAI-1 in 11Z cells treated with indicated conditions for 12 days (n = 3). Values are normalized to the GAPDH expression levels. ( D ) Results of SP and CGRP neutralization on cellular proliferation of 11Z cells, as measured by CCK-8 assay (n = 8). The 11Z cells were treated with the indicated conditions for 12 days. ( E ) Results of SP and CGRP neutralization on cell migratory capacity, as evaluated by the scratch assay, of 11Z cells treated with indicated conditions for 12 days. The cells were photographed at 0, 12, 24 and 48 hours, respectively, after being scratched. The distance between two edges that cells traversed was calculated relative to the initial scratch distance as measured with pixel values. Scale bar = 100 μm. ( F ) Results of SP and CGRP neutralization on invasiveness. The representative photomicrographs of the invaded 11Z cells in the transwell assay after indicated treatments (Magnification: × 200). Cells, after 12 days’ indicated treatments, were added to the top of transwells coated with Matrigel and treated as indicated. The total number of cells invaded to the bottom of the transwell was then counted. Scale bar = 100 μm. * or # p < 0.05, ** or ## p < 0.01, *** or ### p < 0.001; N: not statistically significant (p > 0.05). Data are represented in means ± SDs. Symbols of statistical significance: *, **, and *** indicate different significant levels when compared with the untreated cells, while #, ## , and ### indicate different significant levels when compared with the cells treated with the DRG supernatant. * or # p < 0.05; ** or ## p < 0.01; *** or ### p < 0.001.
    Cgrp And Its Fragment (8–37), supplied by Peptide Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgrp and its fragment (8–37)/product/Peptide Institute
    Average 90 stars, based on 1 article reviews
    cgrp and its fragment (8–37) - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    Image Search Results


    SP and CGRP neutralization reverses DRG-induced EMT and FMT in 11Z cells. ( A ) Representative morphology of 11Z cells treated with medium, the DRG supernatant with pre-treatment with aprepitant (10 −6 M), CGRP fragment 8–37 (10 −6 M), or both aprepitant (10 −6 M) and CGRP 8–37 (10 −6 M), or without for 12 days. Scale bar = 100 μm. ( B ) Left panel: Detection of protein levels of E-cadherin by immunoblotting of lysates of 11Z cells treated with indicated condition for 12 days (n = 3). The grouping of blots from the same protein were not cropped, and all protein blots were from the same gel. Right panel: Relative fold change in protein levels of E-cadherin in 11Z cells treated with indicated condition for 12 days (n = 3). ( C ) Relative fold change of gene expression levels of Snai1, Slug, vimentin, N-cadherin, and PAI-1 in 11Z cells treated with indicated conditions for 12 days (n = 3). Values are normalized to the GAPDH expression levels. ( D ) Results of SP and CGRP neutralization on cellular proliferation of 11Z cells, as measured by CCK-8 assay (n = 8). The 11Z cells were treated with the indicated conditions for 12 days. ( E ) Results of SP and CGRP neutralization on cell migratory capacity, as evaluated by the scratch assay, of 11Z cells treated with indicated conditions for 12 days. The cells were photographed at 0, 12, 24 and 48 hours, respectively, after being scratched. The distance between two edges that cells traversed was calculated relative to the initial scratch distance as measured with pixel values. Scale bar = 100 μm. ( F ) Results of SP and CGRP neutralization on invasiveness. The representative photomicrographs of the invaded 11Z cells in the transwell assay after indicated treatments (Magnification: × 200). Cells, after 12 days’ indicated treatments, were added to the top of transwells coated with Matrigel and treated as indicated. The total number of cells invaded to the bottom of the transwell was then counted. Scale bar = 100 μm. * or # p < 0.05, ** or ## p < 0.01, *** or ### p < 0.001; N: not statistically significant (p > 0.05). Data are represented in means ± SDs. Symbols of statistical significance: *, **, and *** indicate different significant levels when compared with the untreated cells, while #, ## , and ### indicate different significant levels when compared with the cells treated with the DRG supernatant. * or # p < 0.05; ** or ## p < 0.01; *** or ### p < 0.001.

    Journal: Scientific Reports

    Article Title: Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis

    doi: 10.1038/s41598-019-39170-w

    Figure Lengend Snippet: SP and CGRP neutralization reverses DRG-induced EMT and FMT in 11Z cells. ( A ) Representative morphology of 11Z cells treated with medium, the DRG supernatant with pre-treatment with aprepitant (10 −6 M), CGRP fragment 8–37 (10 −6 M), or both aprepitant (10 −6 M) and CGRP 8–37 (10 −6 M), or without for 12 days. Scale bar = 100 μm. ( B ) Left panel: Detection of protein levels of E-cadherin by immunoblotting of lysates of 11Z cells treated with indicated condition for 12 days (n = 3). The grouping of blots from the same protein were not cropped, and all protein blots were from the same gel. Right panel: Relative fold change in protein levels of E-cadherin in 11Z cells treated with indicated condition for 12 days (n = 3). ( C ) Relative fold change of gene expression levels of Snai1, Slug, vimentin, N-cadherin, and PAI-1 in 11Z cells treated with indicated conditions for 12 days (n = 3). Values are normalized to the GAPDH expression levels. ( D ) Results of SP and CGRP neutralization on cellular proliferation of 11Z cells, as measured by CCK-8 assay (n = 8). The 11Z cells were treated with the indicated conditions for 12 days. ( E ) Results of SP and CGRP neutralization on cell migratory capacity, as evaluated by the scratch assay, of 11Z cells treated with indicated conditions for 12 days. The cells were photographed at 0, 12, 24 and 48 hours, respectively, after being scratched. The distance between two edges that cells traversed was calculated relative to the initial scratch distance as measured with pixel values. Scale bar = 100 μm. ( F ) Results of SP and CGRP neutralization on invasiveness. The representative photomicrographs of the invaded 11Z cells in the transwell assay after indicated treatments (Magnification: × 200). Cells, after 12 days’ indicated treatments, were added to the top of transwells coated with Matrigel and treated as indicated. The total number of cells invaded to the bottom of the transwell was then counted. Scale bar = 100 μm. * or # p < 0.05, ** or ## p < 0.01, *** or ### p < 0.001; N: not statistically significant (p > 0.05). Data are represented in means ± SDs. Symbols of statistical significance: *, **, and *** indicate different significant levels when compared with the untreated cells, while #, ## , and ### indicate different significant levels when compared with the cells treated with the DRG supernatant. * or # p < 0.05; ** or ## p < 0.01; *** or ### p < 0.001.

    Article Snippet: For inhibitor experiments, cells were pretreated with vehicle or the potent NK1R antagonist aprepitant (Selleckchem) (10 −6 M) or CGRP Fragment 8–37 (CGRP 8–37) (Sigma) (10 −6 M) , a selective competitive antagonist for CGRP receptors, for 1 hour at 37 °C.

    Techniques: Neutralization, Western Blot, Expressing, CCK-8 Assay, Wound Healing Assay, Transwell Assay